Tuberculosis in solid organ transplant patients

Antonio Doblas*, Fernando Alcaide, Natividad Benito, Mercè Gurguí, Julián Torre-Cisneros

*Corresponding author for this work

Research output: Contribution to journalArticleResearchpeer-review

11 Citations (Scopus)


Tuberculosis is an opportunistic infection with high morbidity and mortality in solid organ transplant patients. The reasons for this high morbidity and mortality lie mostly in diagnostic difficulties, which cause delays in starting treatment, and associated pharmaceutical toxicity. There are still major issues and difficulties in managing tuberculosis in solid organ transplant patients. These include problems due to interactions between antituberculosis and immunosuppressant drugs, the high risk of toxicity of antituberculosis drugs (particularly in liver transplant patients) and the absence of clear indications for the treatment of latent tuberculous infection. This article updates current understanding of tuberculosis in solid organ transplant patients.

Original languageAmerican English
Pages (from-to)34-39
Number of pages6
JournalEnfermedades Infecciosas y Microbiologia Clinica
Issue numberSUPPL.2
Publication statusPublished - Mar 2012


  • Latent tuberculous infection
  • Mycobacterium tuberculosis
  • Solid organ transplantation
  • Tuberculosis


Dive into the research topics of 'Tuberculosis in solid organ transplant patients'. Together they form a unique fingerprint.

Cite this